ClinicalTrials.Veeva

Menu

Metabolic Changes as a Diagnostic Indicator for Cancer

H

Hasselt University

Status

Completed

Conditions

Breast Cancer
Lung Cancer

Treatments

Other: Venous blood sample

Study type

Observational

Funder types

Other

Identifiers

NCT02362776
09/046U

Details and patient eligibility

About

This study aims to determine whether metabolic changes occur in blood plasma of cancer patients, and whether these changes can be used as a biomarker to detect cancer. These analyses will be done by means of nuclear magnetic resonance (NMR) spectroscopy.

Enrollment

426 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Diagnosis of breast or lung cancer (new lesion)

Exclusion criteria

  • Not fasted for at least 6 hours
  • Plasma glucose concentration ≥ 200 mg/dl
  • Intake of medication at the day of investigation
  • History/treatment of cancer in the previous 5 years

Trial design

426 participants in 3 patient groups

breast cancer patients
Treatment:
Other: Venous blood sample
lung cancer patients
Treatment:
Other: Venous blood sample
control subjects
Treatment:
Other: Venous blood sample

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems